HEPATIC HAEMATOMA side effect
What is HEPATIC HAEMATOMA ?HEPATIC HAEMATOMA : Erlotinib Side Effects Report #5588171-5
Physician from FRANCE reported ERLOTINIB problem on Dec 24, 2007. Male patient, 50 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: hepatic haematoma, . ERLOTINIB dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.
HEPATIC HAEMATOMA : Piperacillin Side Effects Report #5474685-5
PIPERACILLIN AND TAZOBACTAM problem was reported by a Health Professional from FINLAND on Sept 20, 2007. Male patient was diagnosed with infection, prophylaxis, pain, prophylaxis against gastrointestinal ulcer, blood glucose abnormal and was treated with PIPERACILLIN AND TAZOBACTAM. After drug was administered, patient experienced the following problems/side effects: hepatic haematoma, post procedural haemorrhage, thrombocytopenia, . PIPERACILLIN AND TAZOBACTAM dosage: unknown. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, KLEXANE, FENTANYL, PANTOPRAZOLE, OXYCODONE HYDROCHLORIDE, INSULIN ACTRAPID, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
HEPATIC HAEMATOMA : Simulect Side Effects Report #5669588-7
Physician from SWITZERLAND reported SIMULECT problem on Mar 07, 2008. Male patient, 49 years of age, was diagnosed with liver transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, hepatic haematoma, pyrexia, systemic inflammatory response syndrome, . SIMULECT dosage: 20 MG, ONCE/SINGLE. During the same period patient was treated with POLYMYCIN B SULPHATE, NEOMYCIN, DAFALGAN, HEPARIN, NEXIUM, ADALAT. Patient was hospitalized. Patient recovered.
HEPATIC HAEMATOMA : Erlotinib Side Effects Report #5681115-7
ERLOTINIB problem was reported by a Physician from FRANCE on Mar 11, 2008. Male patient, 50 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: cholangitis, hepatic haematoma, . ERLOTINIB dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.
HEPATIC HAEMATOMA : Revlimid Side Effects Report #5575482-2
Health Professional from UNITED STATES reported REVLIMID problem on Dec 14, 2007. Female patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: dry skin, hepatic haematoma, pancytopenia, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
HEPATIC HAEMATOMA : Betaseron Side Effects Report #5397020-X
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient, 50 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: gallbladder disorder, hepatic haematoma, liver function test abnormal, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
HEPATIC HAEMATOMA : Betaseron Side Effects Report #5397020-X
Consumer or non-health professional from UNITED STATES reported BETASERON problem on July 13, 2007. Female patient, 50 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: gallbladder disorder, hepatic haematoma, liver function test abnormal, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
HEPATIC HAEMATOMA : Betaseron Side Effects Report #5450407-9
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 50 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: gallbladder disorder, hepatic enzyme increased, hepatic haematoma, liver function test abnormal, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.